Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and ...
BERLIN, Aug 1 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab will invest 1.3 billion euros ($1.40 billion) in a new insulin production facility at its existing site in Frankfurt, where ...
Germany's ruling coalition has been actively working to attract healthcare investments. The site in Frankfurt's Hoechst district is known for producing the company's insulin brand, Lantus. Up Next: ...
Millions of patients rely on insulin. But with new drugs, some have been able to lower their doses or stop taking it altogether. By Dani Blum For over 20 years, Betsy Chadwell carried her insulin pens ...
In a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into a person with type 1 diabetes. The cells pumped out sugar-regulating insulin for months — without the ...
Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at two-year follow-up
In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback